About the Collaborative
The Sontag Foundation is one of five funding partners of the Brain Tumor Funders' Collaborative. This collaborative partnership is accelerating progress in brain tumor research through supporting innovative research and strategic collaborations which would normally be beyond the scope of any of the individual funding organizations.
- BTFC is requesting proposals on the role of the neuro-immune system in the origin and progression of the immune response in primary human brain tumors with the hope of developing immunotherapies for treatment of these tumors in patients. Pre-proposals deadline: May 11, 2018.
- Funding international collaboration to evaluate long term survivors of GBM: Dana-Farber Cancer Institute in support of European Organisation for Research and Treatment of Cancer (EORTC)
Project Managers: Michael Weller, M.D. and Co-PM: Patrick Yung Wen, M.D. “Molecular genetic host-derived and clinical determinants of long-term survival in glioblastoma” .